You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Wireless, implantable optofluidic systems for programmed pharmacology and optogenetics
SBC: Neurolux, Inc. Topic: 101Project Summary Abstract Neuroscience research over the last decade has been revolutionized by many technological advancementsPharmacology and optogenetics represent two distinctand sometimes complementary tools used in neuroscience research to study the central and peripheral nervous systems in the context of the BRAIN initiativeAdvanced interrogations of underlying neural circuits and biology ar ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission
SBC: EDEN PARK ILLUMINATION, INC. Topic: NIAIDDrug resistant bacteria such as MRSAand airborne transmitted microbes such as influenza and TBpresent significant health issueswith major healthcare and economic consequencesUV light is a well established highly efficient anti microbial modalityeffective both against both bacteria and virusesHowever it is not possible to use UV sterilization in scenarios where people are present because it is both ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing a peptide-based oral drug to prevent kidney stones
SBC: Oxalo Therapeutics, Inc. Topic: 400Project Summary Abstract Kidney stonesKSare highly prevalentexcruciatingand associated with long term complications of chronic kidney diseaseCKDand end stage renal diseaseESRDThey account forM ER visits and andgt $B of medical costs annually and have a striking recurrence rate ofinyears and up toinyearsreflecting the inadequacies of current interventionsof KS are composed of calcium oxalate and sm ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
4-(Aminomethyl) benzamides as novel anti-Ebola agents
SBC: Chicago Biosolutions, Inc. Topic: NIAIDEbolaEBOVand MarburgMARVviruses belong to the Filoviridae family and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction after an incubation period ofdaysDue to safety concernsthese viruses are designated as biosafety levelagentsCurrentlythere is no effective vaccine or therapeutic treatment for filoviral infections in humansAfrica has recentlysuffered a lethal EBOV e ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy
SBC: Nano Biotherapeutics, Inc. Topic: NHLBISepsis induced ALI ARDS is a devastating syndrome of acute respiratory failure in critically ill patients that accounts for among the highest admission rates in ICU and mortalityDuring STTR Phasewe at Cell Biologics Incdemonstrated that piceatannola naturally occurring anti inflammatory that selectively inhibits Syk tyrosine kinasewhen entrapped in innm albumin nanoparticlesPANPswas therapeuticall ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Newborn Infant Vision Test
SBC: Precision Vision, Inc. Topic: NProject Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
